Proof of Concept: Trans-atrial AngioVac Aspiration of Mitral Valve Thrombosis in a COVID-19 Patient.
Gino GerosaMatteo PonzoniGiuseppe EvangelistaChiara TessariIvo TiberioAngelo MolèFabio ZanellaDemetrio PittarelloVincenzo TarziaPublished in: ASAIO journal (American Society for Artificial Internal Organs : 1992) (2023)
In patients with a prohibitive surgical risk, the AngioVac cannula can be used to remove left-sided cardiac masses, as an off-label adaptation of the device. We herein describe a novel micro-invasive approach to gain access to the left atrium for the aspiration of a mitral valve mass in a patient affected by severe coronavirus disease 2019. Through a right anterior mini-thoracotomy, the right superior pulmonary vein was accessed and used to insert the aspiration cannula. A parallel venous-arterial extracorporeal membrane oxygenation (ECMO)-like circuit provided circulatory and respiratory support to ensure proper intra- and postoperative hemodynamic stabilization.
Keyphrases
- extracorporeal membrane oxygenation
- mitral valve
- coronavirus disease
- acute respiratory distress syndrome
- ultrasound guided
- left atrial
- respiratory failure
- left ventricular
- case report
- sars cov
- respiratory syndrome coronavirus
- fine needle aspiration
- pulmonary embolism
- mechanical ventilation
- atrial fibrillation
- magnetic resonance imaging
- early onset
- computed tomography
- left atrial appendage
- transcatheter aortic valve replacement
- aortic valve replacement